AERIE PHARMACEUTICALS INC 4 SEC Filings

Filed On	Filing
21 Nov 2022	Form 4: Calabrese Jeffrey, Vice President of Finance Returned 18,585 shares to the issuer ($283K) · Disposed of 27,031 Stock Option (right to buy) (Disposition to Issuer) ($170K)
21 Nov 2022	Form 4: McHugh Julie, Director Returned 16,095 shares to the issuer ($245K) · Disposed of 24,654 Stock Option (right to buy) (Disposition to Issuer) ($169K)
21 Nov 2022	Form 4: Mcgraw Benjamin F Iii, Director Returned 41,984 shares to the issuer ($640K) · Disposed of 127,066 Stock Option (right to buy) (Disposition to Issuer) ($544K)
21 Nov 2022	Form 4: McDonnell Peter J, Director Returned 7,995 shares to the issuer ($122K) · Disposed of 16,854 Stock Option (right to buy) (Disposition to Issuer) ($154K)
21 Nov 2022	Form 4: Kopczynski Casey C., Chief Scientific Officer Returned 280,244 shares to the issuer ($4.27M) · Disposed of 90,941 Stock Option (right to buy) (Disposition to Issuer) ($728K)
21 Nov 2022	Form 4: Lang Peter Frederick, Chief Financial Officer Returned 46,297 shares to the issuer ($706K) · Disposed of 160,551 Stock Option (right to buy) (Disposition to Issuer) ($1.04M)
21 Nov 2022	Form 4: LaRocca John, General Counsel Returned 53,585 shares to the issuer ($817K) · Disposed of 65,941 Stock Option (right to buy) (Disposition to Issuer) ($425K)
21 Nov 2022	Form 4: Gryska David W, Director Returned 13,491 shares to the issuer ($206K) · Disposed of 24,654 Stock Option (right to buy) (Disposition to Issuer) ($169K)
21 Nov 2022	Form 4: du Toit Michael, Director Returned 16,095 shares to the issuer ($245K) · Disposed of 24,654 Stock Option (right to buy) (Disposition to Issuer) ($169K)
21 Nov 2022	Form 4: Croarkin Richard, Director Returned 16,095 shares to the issuer ($245K) · Disposed of 49,654 Stock Option (right to buy) (Disposition to Issuer) ($290K)
21 Nov 2022	Form 4: Kannan Raj, Director Returned 215,783 shares to the issuer ($3.29M) · Disposed of 584,408 Stock Option (right to buy) (Disposition to Issuer) ($4.04M)
03 Nov 2022	Form 4: Calabrese Jeffrey, Vice President of Finance Gave up 179 shares to cover exercise price or tax ($2.72K)
16 Aug 2022	Form 4: LaRocca John, General Counsel Gave up 771 shares to cover exercise price or tax ($8.92K)
16 Aug 2022	Form 4: Calabrese Jeffrey, Vice President of Finance Gave up 265 shares to cover exercise price or tax ($3.07K)
13 Jul 2022	Form 4: Calabrese Jeffrey, Vice President of Finance Gave up 266 shares to cover exercise price or tax ($2.22K)
06 Jul 2022	Form 4: Calabrese Jeffrey, Vice President of Finance Received 11,276 shares as a grant or award · Granted 20,774 Stock Option (right to buy)
13 Jun 2022	Form 4: McHugh Julie, Director Received 6,245 shares as a grant or award · Granted 16,854 Stock Option (right to buy)
13 Jun 2022	Form 4: Mcgraw Benjamin F Iii, Director Received 6,245 shares as a grant or award · Granted 16,854 Stock Option (right to buy)
13 Jun 2022	Form 4: McDonnell Peter J, Director Received 6,245 shares as a grant or award · Granted 16,854 Stock Option (right to buy)
13 Jun 2022	Form 4: Gryska David W, Director Received 6,245 shares as a grant or award · Granted 16,854 Stock Option (right to buy)

Comments